HOME › DRUGS › TABELECLEUCEL
ACTIVE SUBSTANCE / INN

TABELECLEUCEL

Brand name(s): Ebvallo
EMA LISTED
AUTHORISED
Lymphoproliferative Disorders
ACTIVE SUBSTANCE
Tabelecleucel
REGULATORS
EMA
SPONSORS / MAH
Pierre Fabre Medicament
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EbvalloPierre Fabre MedicamentAuthorised16/12/2022Lymphoproliferative Disorders

FULL INTELLIGENCE ON TABELECLEUCEL

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →